Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-003460
Filing Date
2017-01-12
Accepted
2017-01-12 11:31:37
Documents
1
Period of Report
2017-01-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 21206
  Complete submission text file 0001209191-17-003460.txt   22696
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 400-1001 WEST BROADWAY VANCOUVER A1 V6H 4B1
Business Address
Cormack Scott Daniel (Reporting) CIK: 0001442675 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 17524489